- call +1-201-465-4211
- email sales@mrinsights.biz
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
Scope of the Report:
This report focuses on the Alzheimer’s Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Europe is estimated to grow at a rapid pace owing to the high prevalence of AD coupled with ever improving diagnostic capabilities. Asia Pacific is expected to witness the fastest growth over the forecast period owing to the rising disposable income level.
The worldwide market for Alzheimer’s Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Pfizer, Inc.
Merck & Co. Inc.
Novartis AG
Eisai Co. Ltd.
H. Lundbeck A/S
AC Immune
TauRx Pharmaceuticals Ltd.
Actavis plc.
Forest Laboratories
Teva Pharmaceuticals Industries Ltd.
Janssen Pharmaceutical
GE healthcare
Eli Lilly And Company
DiaGenic ASA
VTV Therapeutics
Hoffman-La Roche Ltd.
AstraZeneca
Daiichi Sankyo Company Ltd.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Donepezil
Memantine
Rivastigmine
Market Segment by Applications, can be divided into
Early to Moderate Stages
Moderate to Severe Stages
There are 15 Chapters to deeply display the global Alzheimer’s Therapeutics market.
Chapter 1, to describe Alzheimer’s Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Alzheimer’s Therapeutics, with sales, revenue, and price of Alzheimer’s Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Alzheimer’s Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Alzheimer’s Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Alzheimer’s Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Alzheimer’s Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Donepezil
1.2.2 Memantine
1.2.3 Rivastigmine
1.3 Market Analysis by Applications
1.3.1 Early to Moderate Stages
1.3.2 Moderate to Severe Stages
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer, Inc.
2.1.1 Business Overview
2.1.2 Alzheimer’s Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer, Inc. Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck & Co. Inc.
2.2.1 Business Overview
2.2.2 Alzheimer’s Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck & Co. Inc. Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis AG
2.3.1 Business Overview
2.3.2 Alzheimer’s Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis AG Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eisai Co. Ltd.
2.4.1 Business Overview
2.4.2 Alzheimer’s Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eisai Co. Ltd. Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 H. Lundbeck A/S
2.5.1 Business Overview
2.5.2 Alzheimer’s Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 H. Lundbeck A/S Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AC Immune
2.6.1 Business Overview
2.6.2 Alzheimer’s Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AC Immune Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 TauRx Pharmaceuticals Ltd.
2.7.1 Business Overview
2.7.2 Alzheimer’s Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 TauRx Pharmaceuticals Ltd. Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Actavis plc.
2.8.1 Business Overview
2.8.2 Alzheimer’s Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Actavis plc. Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Forest Laboratories
2.9.1 Business Overview
2.9.2 Alzheimer’s Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Forest Laboratories Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Teva Pharmaceuticals Industries Ltd.
2.10.1 Business Overview
2.10.2 Alzheimer’s Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Teva Pharmaceuticals Industries Ltd. Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Janssen Pharmaceutical
2.11.1 Business Overview
2.11.2 Alzheimer’s Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Janssen Pharmaceutical Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 GE healthcare
2.12.1 Business Overview
2.12.2 Alzheimer’s Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 GE healthcare Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Eli Lilly And Company
2.13.1 Business Overview
2.13.2 Alzheimer’s Therapeutics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Eli Lilly And Company Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 DiaGenic ASA
2.14.1 Business Overview
2.14.2 Alzheimer’s Therapeutics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 DiaGenic ASA Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 VTV Therapeutics
2.15.1 Business Overview
2.15.2 Alzheimer’s Therapeutics Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 VTV Therapeutics Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Hoffman-La Roche Ltd.
2.16.1 Business Overview
2.16.2 Alzheimer’s Therapeutics Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Hoffman-La Roche Ltd. Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 AstraZeneca
2.17.1 Business Overview
2.17.2 Alzheimer’s Therapeutics Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 AstraZeneca Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Daiichi Sankyo Company Ltd.
2.18.1 Business Overview
2.18.2 Alzheimer’s Therapeutics Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Daiichi Sankyo Company Ltd. Alzheimer’s Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Alzheimer’s Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Alzheimer’s Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Alzheimer’s Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Alzheimer’s Therapeutics Manufacturer Market Share in 2017
3.3.2 Top 6 Alzheimer’s Therapeutics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Alzheimer’s Therapeutics Market Analysis by Regions
4.1 Global Alzheimer’s Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Alzheimer’s Therapeutics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Alzheimer’s Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
5 North America Alzheimer’s Therapeutics by Countries
5.1 North America Alzheimer’s Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Alzheimer’s Therapeutics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Alzheimer’s Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
6 Europe Alzheimer’s Therapeutics by Countries
6.1 Europe Alzheimer’s Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Alzheimer’s Therapeutics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Alzheimer’s Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Alzheimer’s Therapeutics by Countries
7.1 Asia-Pacific Alzheimer’s Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Alzheimer’s Therapeutics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Alzheimer’s Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
8 South America Alzheimer’s Therapeutics by Countries
8.1 South America Alzheimer’s Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Alzheimer’s Therapeutics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Alzheimer’s Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Alzheimer’s Therapeutics by Countries
9.1 Middle East and Africa Alzheimer’s Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Alzheimer’s Therapeutics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Alzheimer’s Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Alzheimer’s Therapeutics Sales and Growth Rate (2013-2018)
10 Global Alzheimer’s Therapeutics Market Segment by Type
10.1 Global Alzheimer’s Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Alzheimer’s Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Alzheimer’s Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Donepezil Sales Growth and Price
10.2.1 Global Donepezil Sales Growth (2013-2018)
10.2.2 Global Donepezil Price (2013-2018)
10.3 Memantine Sales Growth and Price
10.3.1 Global Memantine Sales Growth (2013-2018)
10.3.2 Global Memantine Price (2013-2018)
10.4 Rivastigmine Sales Growth and Price
10.4.1 Global Rivastigmine Sales Growth (2013-2018)
10.4.2 Global Rivastigmine Price (2013-2018)
11 Global Alzheimer’s Therapeutics Market Segment by Application
11.1 Global Alzheimer’s Therapeutics Sales Market Share by Application (2013-2018)
11.2 Early to Moderate Stages Sales Growth (2013-2018)
11.3 Moderate to Severe Stages Sales Growth (2013-2018)
12 Alzheimer’s Therapeutics Market Forecast (2018-2023)
12.1 Global Alzheimer’s Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Alzheimer’s Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Alzheimer’s Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Alzheimer’s Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Alzheimer’s Therapeutics Market Forecast (2018-2023)
12.2.4 South America Alzheimer’s Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Alzheimer’s Therapeutics Market Forecast (2018-2023)
12.3 Alzheimer’s Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Alzheimer’s Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Alzheimer’s Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Alzheimer’s Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Alzheimer’s Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Alzheimer’s Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Alzheimer’s Therapeutics Picture
Table Product Specifications of Alzheimer’s Therapeutics
Figure Global Sales Market Share of Alzheimer’s Therapeutics by Types
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
